Meet our team

5AM’s investment professionals possess strong scientific, medical, operational, legal and financial expertise. Our complementary backgrounds provide us with a unique edge to find and shape life science portfolio companies.

Investment Team

Kush M Parmar, MD, PhD

Managing Partner
Andy J. Schwab

Managing Partner
Jamil M. Beg

Partner
Brian Daniels, MD

Partner
Rebecca Lucia, CFA

Partner, Chief Financial Officer / Chief Operating Officer
Deborah Palestrant, PhD

Partner; Executive Chair, 4:59 Initiative
Anna Yaeger

Partner and Head of Public Equities
Jessica Alfano, Esq.

Director of Operations and Senior Corporate Counsel, 4:59 Initiative
Kamila Bajerski

Assistant Controller
Galya Blachman, PhD, Esq

General Counsel and Chief Compliance Officer; COO, 4:59 Initiative
Jacquelyn Brough, CPA

Vice President, Finance
Brian Chow, PhD

Senior Associate
Kevin Corsini Rosewood

Office Manager and Administrative Assistant
John D. Diekman, PhD

FOUNDING PARTNER
Britt Inga Emerson

Investor Relations Manager
Max Farina, MD

Associate
Russ Henspeter

Assistant Controller
Michelle Ho, PhD

Operating Principal
Peter S. Kim, PhD

Venture Advisor
Michael P. Klein, MD

Principal
Jennifer Kozub

Operations Manager and Executive Assistant
June H. Lee, MD FACCP

Venture Partner
Elliott Levy, MD

Venture Partner
Joe Loscalzo, MD, PhD

Venture Advisor
Denise Lyle

Vice President, Human Resources
Chrisoula Markoulakis

Executive Assistant
Vamsi Mootha, MD

Venture Advisor
Bella Nittolo

Office Coordinator and Administrative Assistant
Kori Rahaim

Vice President, Head of People, 4:59 Initiative
Scott M. Rocklage, PhD

FOUNDING PARTNER
Paula Soteropoulos

Venture Partner
Katie Bodner Spielberg, PhD

Associate
Arthur Tzianabos, PhD

Venture Partner
Joseph J. Victor

Venture Advisor
Jenny Wang, CPA

Director, Tax
Mostafa Wassel, J.D.

Paralegal II
Jonathan Weissman, PhD

Venture Advisor
Gloria Wu, MD., PhD

Associate
Lindsay Ziegler

Compliance Manager